Table 4.
Laboratory data comparison of pSS patients with sensorimotor neuropathy and other neuropathies
| Characteristics | Sensorimotor neuropathy (n = 11) | Other neuropathies (n = 12) | p‐Value |
|---|---|---|---|
| Disease duration (years, mean ± SD) | 5.82 ± 3.82 | 1.67 ± 1.07 | .012 |
| Positive anti‐Ro/SS‐A | 10 (91%) | 6 (50%) | .044 |
| Positive anti‐La/SS‐B | 7 (63%) | 3 (25%) | .073 |
| Cryoglobulins | 3 (27%) | 0 (0%) | .093 |
| Hypocomplementemia | 6 (55%) | 0 (0%) | .004 |
| Hypergammaglobulinemia | 9 (82%) | 4 (33%) | .025 |
| B−2‐microglobulin > 2.6 mg/L | 10 (91%) | 2 (17%) | .00055 |
| ESSDAI (mean ± SD) | 7.18 ± 7.1 | 6.83 ± 6.87 | .927 |
| SSDDI (mean ± SD) | 5.73 ± 3 | 3.67 ± 1.44 | .133 |
| ODSS (mean ± SD) | 2.36 ± 1.8 | 1.25 ± 2.49 | .051 |
Abbreviations: ESSDAI EULAR, Sjögren's Syndrome Disease Activity Index; ODSS, Overall Disability Sum Score; pSS, primary Sjögren's syndrome; SSDDI, Sjögren's Syndrome Disease Damage Index.
The results with statistical significance p<.05 are shown in bold.